Cor Vasa 2009, 51(11-12):805-812 | DOI: 10.33678/cor.2009.194

Chronic heart failure - focused on women

Alexander Klabník1,*, Ján Murín2
1 Kardiologické oddelenie, Stredoslovenský ústav srdcových a cievnych chorôb, Banská Bystrica
2 I. interná klinika, Fakultná nemocnica s poliklinikou a Lekárska fakulta Univerzity Komenského, Bratislava, Slovenská republika

The issue of cardiovascular diseases in women is often disregarded. There are significant differences in the epidemiology, morbidity, mortality, diagnosis, etiology, risk factors, comorbidities, in response to pharmacotherapy and non-pharmacological treatment between women and men with chronic heart failure. While this issue has received due attention in developed countries in recent years, no review article on this topic has been published in our journals yet.

Keywords: Gender; Sex; Women; Heart failure

Published: November 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Klabník A, Murín J. Chronic heart failure - focused on women. Cor Vasa. 2009;51(11-12):805-812. doi: 10.33678/cor.2009.194.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Remme WJ, McMurray JJV, Rauch B, et al. Public awareness of heart failure in Europe: first results from SHAPE. Eur Heart J 2005;26:2413-21. Go to original source... Go to PubMed...
    2. Stramba-Badiale M, Fox KM, Priori SG, et al. Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology. Eur Heart J 2006;27:994-1005. Go to original source... Go to PubMed...
    3. Nieminen MS, Harjola VP, Hochadel M, et al. Gender related differences in patients presenting with acute heart failure. Results from EuroHeart Failure Survey II. Eur J Heart Fail 2008;10:140-8. Go to original source... Go to PubMed...
    4. Akar F, Manavbasi Y, Parlar AI, Ulus AT, Katircioglu SF. The gender differences in the relaxation to levosimendan of human internal mammary artery. Cardiovasc Drugs Ther 2007;21:331-8. Go to original source... Go to PubMed...
    5. Yildiz O, Seyrek M, Yildirim V, Demirkilic U, Nacitarhan C. Potassium channel-related relaxation by levosimendan in the human internal mammary artery. Ann Thorac Surg 2006;81:1715-9. Go to original source... Go to PubMed...
    6. Usta C, Eksert B, Golbasi I, Bigat Z, Ozdem SS. The role of potassium channels in the vasodilatory effect of levosimendan in human internal thoracic arteries. Eur J Cardiothorac Surg 2006;30:329-32. Go to original source... Go to PubMed...
    7. Martínez-Sellés M, Robles JAG, Prieto L, et al. Systolic dysfunction is a predictor of long term mortality in men but not in women with heart failure. Eur Heart J 2003;24:2046-53. Go to original source... Go to PubMed...
    8. Lenzen MJ, Scholte op Reimer WJM, Boersma E, et al. Differences between patients with preserved and depressed left ventricular function: a report from the EuroHeart Failure Survey. Eur Heart J 2004;25:1214-20. Go to original source... Go to PubMed...
    9. Goode KM, Nabb S, Cleland JG, Clark AL. A comparison of patient and physician-rated New York Heart Association class in a community based heart failure clinic. J Card Fail 2008;14:379-87. Go to original source... Go to PubMed...
    10. Ammar KA, Jacobsen SJ, Mahoney DW, et al. Prevalence and prognostic significance of heart failure stages. Application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community. Circulation 2007;115:1563-70. Go to original source... Go to PubMed...
    11. Schocken DD, Arriata MI, Laever PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992;20:301-6. Go to original source... Go to PubMed...
    12. Bleumink GS, Knetsch AM, Sturkenboom MC, et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. Eur Heart J 2004;25:1614-9. Go to original source... Go to PubMed...
    13. Ghali JK, Cooper R, Ford E. Trends in rates for heart failure in the United States 1973-1986: evidence for increasing population prevalence. Arch Intern Med 1990;150:769-73. Go to original source...
    14. Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2003;347:1397-402. Go to original source... Go to PubMed...
    15. Roger VL, Weston SA, Redfield MM, et al. Trends in heart failure incidence and survival in a community-based population. JAMA 2004;292:344-50. Go to original source... Go to PubMed...
    16. Spencer FA, Meyer TE, Goldberg RJ, et al. Twenty year trends (1975-1995) in the incidence, in-hospital and long-term death rates associated with heart failure complicating acute myocardial infarction: a community- wide perspective. J Am Coll Cardiol 1999;34:1378-87. Go to original source... Go to PubMed...
    17. Komajda M, Follath F, Swedberg K, et al. The Euro Heart Failure Survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J 2003;24:464-75. Go to original source... Go to PubMed...
    18. Mezu U, Bott-Silverman C, Hsich E. Heart failure in women is different than in men; should treatment be different? Clev Clin J Med 2007;74:423-35. Go to original source... Go to PubMed...
    19. Henzlova MJ, Blackburn GH, Bradley EJ, Rogers WJ, for the SOLVD Close-Out Working Group. Patient perception of a long-term clinical trial: experience using a close-out questionnaire in the Studies of Left Ventricular Dysfunction. Control Clin Trials 1994;5:284-93. Go to original source... Go to PubMed...
    20. McMurray JJV, McDonagh TA, Morrison CE, Dargie HJ. Trends in hospitalisation for heart failure in Scotland. Eur Heart J 1993;14:1158-62. Go to original source... Go to PubMed...
    21. Burns RB, McCarthy EP, Moskowitz MA, Ash A. Outcomes for older men and women with congestive heart failure. J Am Geriatr Soc 1997;45:276-8. Go to original source... Go to PubMed...
    22. Krumholz HM, Parnt EM, Tu N, et al. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med 1997;157:99-104. Go to original source...
    23. Braunstein JB, Anderson GF, Gerstenblith G, et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among medicare beneficiaries with chronic heart failure. J Am Coll Cardiol 2003;42:1226-33. Go to original source... Go to PubMed...
    24. Fonarow GC, Abraham WT, Albert NM, et al. Factors identified as precipitating hospital admissions for heart failure and clinical outcomes. Findings from OPTIMIZE-HF. Arch Intern Med 2008;168:847-54. Go to original source... Go to PubMed...
    25. Ho KK, Anderson KM, Kannel WB, Groosman W, Levy D. Survival after the onset of congestive heart failure in Framingham heart study subjects. Circulation 1993;88:107-15. Go to original source... Go to PubMed...
    26. Bourassa MG, Gurne O, Bangdiwala SI, et al. Natural history and current practices in heart failure. J Am Coll Cardiol 1993;22 (Suppl):14A-19A. Go to original source... Go to PubMed...
    27. Vaccarino V, Chen YT, Wang Y, et al. Sex differences in the clinical care and outcomes of congestive heart failure in the elderly. Am Heart J 1999;138:835-42. Go to original source... Go to PubMed...
    28. Opasich C, Cafiero M, Scherillo M, et al. The 'real' women with heart failure. Impact of sex on current in-hospital management of heart failure by cardiologists and internists. Eur J Heart Fail 2004;6:769-79. Go to original source... Go to PubMed...
    29. Trenčanská L, Kamenský G, Šidlo R, at al. Hospitalizačná mortalita a jej prediktívne faktory u pacientov s kongestívnym srdcovým zlyhaním. Cardiol 2003;12:33-8.
    30. Laditka JN, Laditka SB. Increased hospitalization risk for recently widowed older women and protective effects of social contacts. Journal of Women&Aging 2003;15:7. Go to original source... Go to PubMed...
    31. Krumholz HM, Butler J, Miller J, et al. The prognostic importance of emotional support for elderly patients hospitalized with heart failure. Circulation 1998;97:958-64. Go to original source... Go to PubMed...
    32. O'Meara E, Clayton T, McEntegart MB, et al. Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Program. Circulation 2007;115:3111-20. Go to original source... Go to PubMed...
    33. Frazier CG, Alexander KP, Newby LK, et al. Associations of gender and etiology with outcomes in heart failure with systolic dysfunction: a pooled analysis of 5 randomized control trials. J Am Coll Cardiol 2007;49:1450-8. Go to original source... Go to PubMed...
    34. Levy WC, Mozaffarian D, Linker DT, et al. The Seattle Heart Failure Model: Prediction of Survival in Heart Failure. Circulation 2006;113:1424-33. Go to original source... Go to PubMed...
    35. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2008; 29:2388-442. Go to original source... Go to PubMed...
    36. Remes J, Miettinen H, Reunanen A, Pyörälä K. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 1991;12:315-21. Go to original source... Go to PubMed...
    37. Wheeldon NM, MacDonald TM, Flucker CJ, et al. Echocardiography in chronic heart failure in the community. QJ Med 1993;86:17-23.
    38. Olofsson M, Edebro D, Boman K. Are elderly patients with suspected HF misdiagnosed? A primary health care center study. Cardiology 2007;107: 226-32. Go to original source... Go to PubMed...
    39. Ingelsson E, Amlöv J, Sundström J, Lind L. The validity of a diagnosis of heart failure in a hospital discharge register. Eur J Heart Fail 2005;7:787-91. Go to original source... Go to PubMed...
    40. Johnstone D, Limacher M, Rousseau M, et al. Clinical characteristics of patients in the Studies of Left Ventricular Dysfunction. Am J Cardiol 1992;70: 894-900. Go to original source... Go to PubMed...
    41. Ritter M, Laule-Kilian K, Klima T, et al. Sex differences in acute congestive heart failure. Swiss Med Weekly 2006;136:311-7.
    42. Mejhert M, Holmgren J, Wändell P, Persson H, Edner M. Diagnostic tests, treatment and follow-up in heart failure patients - is there a gender bias in the coherence to guidelines? Eur J Heart Fail 1999;1:407-10. Go to original source... Go to PubMed...
    43. Senni M, Rodeheffer RJ, Tribouilloy CM, et al. Use of echocardiography in the management of congestive heart failure in the community. J Am Coll Cardiol 1999;33:164-70. Go to original source... Go to PubMed...
    44. Brenden CK, Hollander JE, Guss D, et al. Gray zone BNP levels in heart failure patients in the emergency department: results from the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT) multicenter study. Am Heart J 2006;151:1006-11. Go to original source... Go to PubMed...
    45. Nakamura M, Tanaka F, Onoda T, et al, on behalf of the Iwate KENCO study groups. Gender-specific risk stratification with plasma B-type natriuretic peptide for future onset of congestive heart failure and mortality in the Japanese general population. Int J Cardiol 2009;Mar 8. Epub ahead of print, doi:10.1016/j.icard.2009.01.076. Go to PubMed...
    46. Abboud J, Murad Y, Chen-Scarabelli C, Saravolatz L, Chen-Scarabelli TM. Peripartum cardiomyopathy: comprehensive review. Int J Cardiol 2007;118: 295-303. Go to original source... Go to PubMed...
    47. Berko BA, Swift M. X-linked dilated cardiomyopathy. N Engl J Med 1987;316: 1186-91. Go to original source... Go to PubMed...
    48. Urbano-Marquez A, Estruch R, Fernandeez-Sola J, Nicolas M, Pare JC, Rubin E. The greater risk of alcoholic cardiomyopathy and myopathy in women compared with men. JAMA 1995;274:149-54. Go to original source... Go to PubMed...
    49. Lipshultz SE, Lipsitz SR, Mone SM, et al. Female sex and drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N Engl J Med 1995;332:1738-43. Go to original source... Go to PubMed...
    50. Gianni M, Dentali F, Grandi AM, et al. Apical ballooning syndrome or Takotsubo cardiomyopathy: a systematic review. Eur Heart J 2006;27:1523-9. Go to original source... Go to PubMed...
    51. Tofler GH, Stone PH, Mueller JE, et al. Effects of gender and race on prognosis after myocardial infarction: adverse prognosis for women, particularly black women. J Am Coll Cardiol 1987;9:473-82. Go to original source... Go to PubMed...
    52. Levy D, Larson MG, Vasan RS, et al. The progression from hypertension to congestive heart failure. JAMA 1996;275:1557-62. Go to original source...
    53. Keyhani S, Scobie JV, Hebert PL, McLaughlin MA. Gender disparities in blood pressure control and cardiovascular care in a national sample of ambulatory care visits. Hypertension 2008;51:1149-55. Go to original source... Go to PubMed...
    54. He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med 2001;161:996-1002. Go to original source... Go to PubMed...
    55. Fonarow GC, Abraham WT, Albert NM, et al. A smoker's paradox in patients hospitalized for heart failure: findings from OPTIMIZE-HF. Eur Heart J 2008; 29:1983-91. Go to original source... Go to PubMed...
    56. Amsalem Y, Garty M, Schwartz R, et al. Prevalence and significance of unrecognized renal insufficiency in patients with heart failure. Eur Heart J 2008;29:1029-36. Go to original source... Go to PubMed...
    57. Maccia A, Monte S, Romero M, D'Ettorre A, Tognoni G. The prognostic influence of chronic obstructive pulmonary disease in patients hospitalised for chronic heart failure. Eur J Heart Fail 2007;9:942-8. Go to original source... Go to PubMed...
    58. Shindler DM, Kostis JB, Yusuf S, et al. Diabetes mellitus: a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry. Am J Cardiol 1996;77:1017-20. Go to original source... Go to PubMed...
    59. Gustafsson I, Brendorp B, Seibaek M, et al, and DIAMOND Study Group. Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure. J Am Coll Cardiol 2004;43:771-7. Go to original source... Go to PubMed...
    60. Ahmed A, Aban IB, Vaccarino V, et al. A propensity-matched study of the effect of diabetes on the natural history of heart failure: variations by sex and age. Heart 2007;93:1584-90. Go to original source... Go to PubMed...
    61. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998;82:2N-9N. Go to original source... Go to PubMed...
    62. Corley SD, Epstein AE, DiMarco JP, et al. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Circulation 2004;109:1509-13. Go to original source... Go to PubMed...
    63. Deedwania PC, Singh BN, Ellenbogen K, et al. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the Veterans Affairs CHF-STAT Investigators. Circulation 1998;98:2574-9. Go to original source... Go to PubMed...
    64. Freudenberger RS, Wilson AC, Kostis JB, and AFFIRM Investigators and Committees. Comparison of rate versus rhythm control for atrial fibrillation in patients with left ventricular dysfunction (from the AFFIRM study). Am J Cardiol 2007;100:247-52. Go to original source... Go to PubMed...
    65. Roy D, Talajic M, Nattel S, et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 2008;358:2667-77. Go to original source... Go to PubMed...
    66. Torp-Pedersen C, Metra M, Spark P, et al. The safety of amiodarone in patients with heart failure. J Card Fail 2007;13:340-5. Go to original source... Go to PubMed...
    67. Essebag V, Reynolds MR, Hadjis T, et al. Sex differences in the relationship between amiodarone use and the need for permanent pacing in patients with atrial fibrillation. Arch Intern Med 2007;167:1648-53. Go to original source... Go to PubMed...
    68. Kober L, Torp-Pedersen C, McMurray JJ, et al. Increased mortality after dronedarone therapy for severe heart failure. N Engl J Med 2008;358:2678-87. Go to original source... Go to PubMed...
    69. Gerstenfeld EP, Callans D, Dixit S, et al. Characteristics of patients undergoing atrial fibrillation ablation: trends over a seven-year period 1999-2005. J Cardiovasc Electrophysiol 2007;18:23-8. Go to original source... Go to PubMed...
    70. Forleo GB, Tondo C, De Luca L, et al. Gender-related differences in catheter ablation of atrial fibrillation. Europace 2007;9:613-20. Go to original source... Go to PubMed...
    71. Dagres N, Clague JR, Breithardt G, Borggrefe M. Significant gender related differences in radiofrequency catheter ablation therapy. J Am Coll Cardiol 2003;42:1103-7. Go to original source... Go to PubMed...
    72. Spragg DD, Dalal D, Cheema A, et al. Complications of catheter ablation for atrial fibrillation: incidence and predictors. J Cardiovasc Electrophysiol 2008;19:627-31. Go to original source... Go to PubMed...
    73. Lenzen MJ, Boersma E, Scholte OP, et al. Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure. Eur Heart J 2005;26:2706-13. Go to original source... Go to PubMed...
    74. Jong P, Gong Y, Liu PP, Austin PC, Lee DC, Tu JV. Care and outcomes of patients newly hospitalized for heart failure in the community treated by cardiologists compared to other specialists. Circulation 2003;108:184-91. Go to original source... Go to PubMed...
    75. Lenzen MJ, Rosengren A, Scholte OP, Reimer WJM. Management of patients with heart failure in clinical practice: differences between men and women. Heart 2008;94:e10. Go to original source... Go to PubMed...
    76. Clinical Quality Improvement Network. Mortality risk and patterns of practice in 4606 acute care patients with congestive heart failure: the relative importance of age, sex and medical therapy. Arch Intern Med 1996; 156:1669-73. Go to original source...
    77. Widimský J, Lánska V, Magulová D, Sachová M. Průzkum stavu aktuální praxe diagnostiky a léčby srdečního selhání v ordinacích všeobecných lékařů v České a Slovenské republice v roce 1999 (2. část programu IMPROVEMENT of HF). Cor Vasa 2001;43:345-52.
    78. Baumhäkel M, Müller U, Böhm M. Influence of gender of physicians and patients on guideline-recommended treatment of chronic heart failure in a cross-sectional study. Eur J Heart Fail 2009;11:299-303. Go to original source... Go to PubMed...
    79. Klabník A, Koštek M, Murín J. Sú ženy s chronickým kardiálnym zlyhávaním diskriminované? IV. tatranské kardiologické dni, Štrbské Pleso, 2.-5. marca 2008 (1. miesto v posterovej sekcii). Cardiol 2008;17:K/C54 (Abstrakt).
    80. Klabnik A, Kostek M, Murin J. Gender differences in clinical profile, new quality markers and in-hospital mortality of chronic heart failure. 16th Alpe Adria Cardiology Congress, Portorož, Slovenia, June 5-7, 2008 (invited lecture). Slovenska Kardiologija 2008;5 (Suppl.1):8 (Abstract).
    81. Klabnik A, Kostek M, Murin J. Women and chronic heart failure - our initial experiences. Den mladých kardiologů 2008, Hradec Králové, 11. jún 2008 (lecture). Cor Vasa 2008;50:K122 (Abstract).
    82. Rumsfeld JS, Masoudi FA. Sex differences: implications for heart failure care. Eur Heart J 2004;25:101-3. Go to original source... Go to PubMed...

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes